SENNA-LAX- sennosides tablet 
Preferred Pharmaceuticals Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Senna-Lax

Drug Facts

Active ingredient

(in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally causes bowel movement in 6-12 hours

Warnings

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

stomach pain, nausea, or vomiting, noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative
 
These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health care professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

preferable at bedtime or a directed by a doctor
adults and children 12 years of age and older: 2 tablets once a day: maximum of 4 tablets once a day
children (6-12 years) 1tablet once a day: maximum 2 tablets once a day
children (2-6 years) ½ tablet once a day: maximum 1 tablet once a day
children under 2 years of age: Ask a doctor

Other information

Store at room temperature, USP
Each tablet contains: Calcium 20 mg

Inactive ingredient

Croscarmellose Sodium, Dicalcium Phosphate, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil and Polyethylene Gycol

Questions or comments? (800) 616-2471

Tamper Evident:

Do not use if sealed blister units are broken or damaged.

Product color may slightly vary due to natural changes of ingredients

Manufactured by:
Contract Pharmacal Corp.
135 Adams Avenue
Hauppauge, NY 11788 USA
www.cpc.com

Distributed By:

MAJOR® PHARMACEUTICALS

31778 Enterprise Drive

Livonia, MI 48150

Rev. 10/15

Repackaged By: Preferred Pharmaceuticals Inc.

Principal Display Panel

Senna-Lax

(Standardized Senna Concentrate)

8.6 mg Sennosides

100 Tablets

Senna Lax
SENNA-LAX 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-6442(NDC:0904-6522)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM SILICATE (UNII: 9B9691B2N9)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
LIGHT MINERAL OIL (UNII: N6K5787QVP)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
Product Characteristics
ColorBROWN (Mottled brown) Scoreno score
ShapeROUNDSize9mm
FlavorImprint Code 1122
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68788-6442-330 in 1 BLISTER PACK; Type 0: Not a Combination Product07/29/2016
2NDC:68788-6442-1100 in 1 BLISTER PACK; Type 0: Not a Combination Product07/29/2016
3NDC:68788-6442-8120 in 1 BLISTER PACK; Type 0: Not a Combination Product06/23/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33407/29/2016
Labeler - Preferred Pharmaceuticals Inc. (791119022)
Registrant - Preferred Pharmaceuticals Inc. (791119022)
Establishment
NameAddressID/FEIBusiness Operations
Preferred Pharmaceuticals Inc.791119022REPACK(68788-6442)

Revised: 6/2017
Document Id: 2efe9976-acb6-4e10-91ca-f676700b7cd6
Set id: b2729b43-d4f4-4ae1-98e4-57227dfb81ae
Version: 2
Effective Time: 20170623
 
Preferred Pharmaceuticals Inc.